Evaluation of microalbuminuria in patients with erectile dysfunction

J Sex Med. 2010 Mar;7(3):1224-8. doi: 10.1111/j.1743-6109.2009.01503.x. Epub 2009 Sep 29.

Abstract

Introduction: The recent sophisticated diagnostic procedures aimed at identifying the exact cause of erectile dysfunction (ED) are often complicated in clinical application, invasive, or highly expensive. Microalbuminuria, a test easy to perform and of low cost, is a marker of extensive endothelial dysfunction, and it has been suggested to be linked to ED.

Aim: The aim of this study was to investigate the eventual role of microalbuminuria in differentiating patients with arteriogenic and non arteriogenic ED.

Methods: The diagnosis of ED was based on the International Index of Erectile Function 5-questionnaire, and patients were classified as arteriogenic (N = 29) and non-arteriogenic (N = 49) in relation to the results of echo-color-doppler examination of cavernosal arteries in basal conditions and after intracavernous injection of 10 microg prostaglandin E(1).

Main outcome measures: The microalbuminuria of 78 males without the most common atheriosclerotic risks and with ED was measured.

Results: Microalbuminuria, defined as urinary albumin/creatinine ratio, was not significantly (P > 0.05) different between patients of the two groups.

Conclusions: Our data show that in ED patients the cavernosal arteries damage, as assessed by dynamic echo-color-doppler, may be independent on or precede extensive endothelial dysfunction, and that microalbuminuria cannot be predictive of penile arteriogenic etiology.

MeSH terms

  • Adult
  • Albuminuria / diagnosis*
  • Albuminuria / epidemiology*
  • Alprostadil / pharmacology
  • Alprostadil / therapeutic use
  • Erectile Dysfunction / drug therapy
  • Erectile Dysfunction / epidemiology*
  • Erectile Dysfunction / urine*
  • Humans
  • Injections
  • Male
  • Middle Aged
  • Penis / drug effects
  • Severity of Illness Index
  • Surveys and Questionnaires
  • Vasodilator Agents / pharmacology
  • Vasodilator Agents / therapeutic use
  • Young Adult

Substances

  • Vasodilator Agents
  • Alprostadil